368 related articles for article (PubMed ID: 33217090)
1. Heterogeneities in administration methods among cannabis users by use purpose and state legalization status: findings from a nationally representative survey in the United States, 2020.
Shi Y
Addiction; 2021 Jul; 116(7):1782-1793. PubMed ID: 33217090
[TBL] [Abstract][Full Text] [Related]
2. Recreational cannabis legalization and transitions in cannabis use: findings from a nationally representative longitudinal cohort in the United States.
Gunadi C; Zhu B; Shi Y
Addiction; 2022 Oct; 117(10):2651-2659. PubMed ID: 35618659
[TBL] [Abstract][Full Text] [Related]
3. In the weeds: a baseline view of cannabis use among legalizing states and their neighbours.
Pacula RL; Jacobson M; Maksabedian EJ
Addiction; 2016 Jun; 111(6):973-80. PubMed ID: 26687431
[TBL] [Abstract][Full Text] [Related]
4. Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use.
Goodwin RD; Kim JH; Cheslack-Postava K; Weinberger AH; Wu M; Wyka K; Kattan M
Addiction; 2021 Oct; 116(10):2770-2778. PubMed ID: 33730400
[TBL] [Abstract][Full Text] [Related]
5. Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws.
Hasin DS; Borodovsky J; Shmulewitz D; Walsh C; Livne O; Struble CA; Aharonovich E; Fink DS; Budney A
Drug Alcohol Depend; 2021 Dec; 229(Pt B):109159. PubMed ID: 34844095
[TBL] [Abstract][Full Text] [Related]
6. Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021.
Hasin DS; Borodovsky J; Shmulewitz D; Walsh C; Struble CA; Livne O; Habib MI; Fink DS; Aharonovich E; Budney A
Addict Behav; 2023 May; 140():107617. PubMed ID: 36736229
[TBL] [Abstract][Full Text] [Related]
7. The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer.
Hawley P; Gobbo M; Afghari N
BMC Health Serv Res; 2020 Oct; 20(1):977. PubMed ID: 33109169
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
Goodman S; Wadsworth E; Leos-Toro C; Hammond D;
Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413
[TBL] [Abstract][Full Text] [Related]
9. Chronic Pain, Cannabis Legalization and Cannabis Use Disorder in Veterans Health Administration Patients, 2005 to 2019.
Hasin DS; Wall MM; Alschuler D; Mannes ZL; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; McDowell Y; Sherman S; Saxon AJ
medRxiv; 2023 Jul; ():. PubMed ID: 37503049
[TBL] [Abstract][Full Text] [Related]
10. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
Hildebrand A; Minnier J; Cameron MH
Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
[TBL] [Abstract][Full Text] [Related]
11. Prices and Purchase Sources for Dried Cannabis Flower in the United States, 2019-2020.
Wadsworth E; Driezen P; Pacula RL; Kilmer B; Hammond D
Cannabis Cannabinoid Res; 2023 Oct; 8(5):923-932. PubMed ID: 35363550
[No Abstract] [Full Text] [Related]
12. A difference-in-difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004-17.
Weinberger AH; Wyka K; Kim JH; Smart R; Mangold M; Schanzer E; Wu M; Goodwin RD
Addiction; 2022 Jun; 117(6):1768-1777. PubMed ID: 34985165
[TBL] [Abstract][Full Text] [Related]
13. The impacts of potency, warning messages, and price on preferences for Cannabis flower products.
Shi Y; Cao Y; Shang C; Pacula RL
Int J Drug Policy; 2019 Dec; 74():1-10. PubMed ID: 31382201
[TBL] [Abstract][Full Text] [Related]
14. Cannabis use among US adults with anxiety from 2008 to 2017: The role of state-level cannabis legalization.
Weinberger AH; Zhu J; Levin J; Barrington-Trimis JL; Copeland J; Wyka K; Kim JH; Goodwin RD
Drug Alcohol Depend; 2020 Sep; 214():108163. PubMed ID: 32707516
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal.
Lapham GT; Matson TE; Bobb JF; Luce C; Oliver MM; Hamilton LK; Bradley KA
JAMA Netw Open; 2023 Aug; 6(8):e2328934. PubMed ID: 37642968
[TBL] [Abstract][Full Text] [Related]
16. The association between recreational cannabis commercialization and cannabis exposures reported to the US National Poison Data System.
Shi Y; Liang D
Addiction; 2020 Oct; 115(10):1890-1899. PubMed ID: 32080937
[TBL] [Abstract][Full Text] [Related]
17. Associations of recreational cannabis dispensaries' availability, storefront signage and health benefit signs with cannabis use: findings from a representative adult sample in California, United States.
Han B; Shi Y
Addiction; 2023 Jul; 118(7):1270-1279. PubMed ID: 36680550
[TBL] [Abstract][Full Text] [Related]
18. Patterns of cannabis use, perception of harm, and perceived impact of legislative change in an online sample of young adults from Lebanon: insight on recreational users versus dual motive users.
Ghandour L; Slim A; Abbas N; El-Khoury J
Harm Reduct J; 2024 Feb; 21(1):41. PubMed ID: 38360652
[TBL] [Abstract][Full Text] [Related]
19. Racial and Ethnic Differences in Cannabis Use Following Legalization in US States With Medical Cannabis Laws.
Martins SS; Segura LE; Levy NS; Mauro PM; Mauro CM; Philbin MM; Hasin DS
JAMA Netw Open; 2021 Sep; 4(9):e2127002. PubMed ID: 34570205
[TBL] [Abstract][Full Text] [Related]
20. State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019.
Hasin DS; Wall MM; Choi CJ; Alschuler DM; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; Mannes Z; Sherman S; Saxon AJ
JAMA Psychiatry; 2023 Apr; 80(4):380-388. PubMed ID: 36857036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
